CN1166402C - 一种具有保健作用的中药组合物 - Google Patents
一种具有保健作用的中药组合物 Download PDFInfo
- Publication number
- CN1166402C CN1166402C CNB011186186A CN01118618A CN1166402C CN 1166402 C CN1166402 C CN 1166402C CN B011186186 A CNB011186186 A CN B011186186A CN 01118618 A CN01118618 A CN 01118618A CN 1166402 C CN1166402 C CN 1166402C
- Authority
- CN
- China
- Prior art keywords
- group
- tried
- influence
- mice
- thing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title description 8
- 239000002131 composite material Substances 0.000 title 1
- 239000000843 powder Substances 0.000 claims abstract description 19
- 241000222336 Ganoderma Species 0.000 claims abstract description 9
- 241000241413 Propolis Species 0.000 claims abstract description 8
- 229940069949 propolis Drugs 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims description 9
- 235000005956 Cosmos caudatus Nutrition 0.000 claims description 7
- 244000293323 Cosmos caudatus Species 0.000 claims description 7
- 238000005728 strengthening Methods 0.000 abstract description 6
- 210000000988 bone and bone Anatomy 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 240000005373 Panax quinquefolius Species 0.000 abstract 1
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract 1
- 230000001256 tonic effect Effects 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 38
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 36
- 241001465754 Metazoa Species 0.000 description 30
- 230000037396 body weight Effects 0.000 description 21
- 210000004369 blood Anatomy 0.000 description 18
- 239000008280 blood Substances 0.000 description 18
- 235000014655 lactic acid Nutrition 0.000 description 18
- 239000004310 lactic acid Substances 0.000 description 18
- 230000009182 swimming Effects 0.000 description 16
- 241000699666 Mus <mouse, genus> Species 0.000 description 15
- 239000002775 capsule Substances 0.000 description 15
- 230000000242 pagocytic effect Effects 0.000 description 12
- 210000002540 macrophage Anatomy 0.000 description 11
- 239000003795 chemical substances by application Substances 0.000 description 10
- 210000002966 serum Anatomy 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 229920002527 Glycogen Polymers 0.000 description 6
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 6
- 229940096919 glycogen Drugs 0.000 description 6
- 239000000047 product Substances 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 210000001541 thymus gland Anatomy 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- 230000002440 hepatic effect Effects 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 108010006464 Hemolysin Proteins Proteins 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000003228 hemolysin Substances 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000000630 rising effect Effects 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007910 chewable tablet Substances 0.000 description 1
- 229940068682 chewable tablet Drugs 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- -1 hydroxyl radical free radical Chemical class 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
组别 | 剂量(g/kg.bw) | 动物数(只) | 脾脏/体重比值(mg/g) | P值 |
空白对照组低剂量组中剂量组高剂量组 | 00.20.41.2 | 12121212 | 5.05±1.265.73±0.885.24±0.825.56±1.03 | -0.14340.66570.4095 |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011186186A CN1166402C (zh) | 2001-06-05 | 2001-06-05 | 一种具有保健作用的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011186186A CN1166402C (zh) | 2001-06-05 | 2001-06-05 | 一种具有保健作用的中药组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1389265A CN1389265A (zh) | 2003-01-08 |
CN1166402C true CN1166402C (zh) | 2004-09-15 |
Family
ID=4663316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB011186186A Expired - Fee Related CN1166402C (zh) | 2001-06-05 | 2001-06-05 | 一种具有保健作用的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1166402C (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103141836A (zh) * | 2013-02-21 | 2013-06-12 | 汤臣倍健股份有限公司 | 兼具增强免疫力功能的瘦身胶囊 |
CN104585732B (zh) * | 2014-12-30 | 2016-05-18 | 广州白云山汉方现代药业有限公司 | 一种灵芝孢子保健食品及其制备方法与缓解体力疲劳应用 |
CN107372954A (zh) * | 2017-07-28 | 2017-11-24 | 明光市昊昊蜂业有限公司 | 一种蜂胶美容养颜茶 |
CN108991453A (zh) * | 2018-08-06 | 2018-12-14 | 重庆市畜牧科学院 | 一种复方纳米蜂胶的制备方法及其产品 |
CN112618589A (zh) * | 2021-01-04 | 2021-04-09 | 王喆鑫 | 一种中药保健药品配方及其制作方法 |
-
2001
- 2001-06-05 CN CNB011186186A patent/CN1166402C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1389265A (zh) | 2003-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1211107C (zh) | 改善血液循环的混合物 | |
CN1631247A (zh) | 一种耐缺氧抗疲劳的保健食品及其制备工艺 | |
CN1840171A (zh) | 慢性肾病营养液及其制备方法 | |
CN1166402C (zh) | 一种具有保健作用的中药组合物 | |
CN1033000A (zh) | 营养品食物和药品的镁添加剂 | |
CN1883527A (zh) | 一种灵芝保健品及其制备方法 | |
CN1868463A (zh) | 一种α-硫辛酸或其衍生物的缓释制剂及其制备方法 | |
CN1253159C (zh) | 一种复合蜂胶保健品及其制备方法 | |
CN101041024A (zh) | 一种治疗结核病的药物组合物及其制备方法 | |
CN1887315A (zh) | 腹可安分散片及其制备方法 | |
CN1768744A (zh) | 制备复方法莫替丁咀嚼片的方法 | |
CN1562337A (zh) | 治疗肾阳虚的中药及其制备方法 | |
CN1212141C (zh) | 苍术油在制备治疗骨质疏松症药物中的应用 | |
CN1869208A (zh) | 虫草sod的制备以及含虫草sod的保健品 | |
CN1651036A (zh) | 独活寄生颗粒及其制备方法 | |
CN1283300C (zh) | 一种治疗糖尿病的中药组合物及其制备方法 | |
CN1686405A (zh) | 一种小儿肠胃康泡腾片及其制备方法 | |
CN1500487A (zh) | 左西替利嗪伪麻黄碱复方口服制剂及制备方法 | |
CN1228079C (zh) | 治疗儿童多动症的口服药物 | |
CN1650895A (zh) | 从天然植物复方制剂中提取增强记忆制品药物的方法 | |
CN1304021C (zh) | 一种药物组合物及其制备方法 | |
CN1247211C (zh) | 含灵芝活性物的片状保健品或药品 | |
CN1943563A (zh) | 维生素滴丸及其制备方法 | |
CN1533805A (zh) | 以南瓜为主要原料制备的治疗便秘的胶囊配方及配制方法 | |
CN1546087A (zh) | 一种以红景天为主的心脑养护保健品及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: BEIJING SHENGGUOTAI TECHNOLOGY CO., LTD. Free format text: FORMER NAME OR ADDRESS: BEIJING XIKAIGUOTAI MEDICINE SCI-TECH CO., LTD. |
|
CP03 | Change of name, title or address |
Address after: 100013, 28 North Third Ring Road, Beijing Yi Building, room 1608 Patentee after: Beijing Saint Pacific Science and Technology Co., Ltd. Address before: 100027 No. 7, Dongxing Road, Beijing, Chaoyang District Patentee before: Beijing Xikaiguotai Medicine Sci-Tech Co., Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: ZHANG MINGLI Free format text: FORMER OWNER: BEIJING SHENGGUOTAI TECHNOLOGY CO., LTD. Effective date: 20070105 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20070105 Address after: 100102, room 1, unit 10, 601 south, Hua Fang, Chaoyang District, Beijing Patentee after: Zhang Mingli Address before: 100013, 28 North Third Ring Road, Beijing Yi Building, room 1608 Patentee before: Beijing Saint Pacific Science and Technology Co., Ltd. |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20040915 Termination date: 20140605 |